3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
14
Breast
3
Sarcoma
1
Other neoplasm
1
Lymphoid
1
Head & Neck
1
Conditions
Precancerous Conditions
1
Esophageal Neoplasms
1
Barrett Esophagus
1
Interventions
Surveys and Questionnaires
9
Cyclophosphamide
9
Whole-Body Irradiation
7
Biopsy
7
fludarabine phosphate
6
Peripheral Blood Stem Cell Transplantation
6
Educational Status
6
Early Intervention, Educational
6
Busulfan
6
Methotrexate
5
Methods
5
Immunohistochemistry
5
Epoetin Alfa
5
Tacrolimus
4
Mycophenolic Acid
4
Interviews as Topic
4
Gene Expression Profiling
4
Decitabine
4
Cyclosporine
4
Celecoxib
4
Antilymphocyte Serum
4
fludarabine
3
Sirolimus
3
Radiotherapy
3
Paclitaxel
3
Microarray Analysis
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
Imiquimod
3
Fentanyl
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Esomeprazole
×
Other neoplasm
×
Clear all
NCT00357682
2025-05-01
AspECT
University of Oxford
Phase 3
Completed
2,557 enrolled
17 charts